ANZCA-response-re-inquiry-into-administration-of-registration-and-notifications-by-AHPRA-20210514
ANZCA letter to Medical Board of Australia Chair Dr Anne Tonkin 20211201
ANZCA's letter to Medical Board of Australia Chair Dr Anne Tonkin re: the Ahpra cosmetic surgery review 1 December 2021
PMC gender equity response
College feedback on the Department of the Prime Minister and Cabinet’s national strategy to achieve gender equity in Australia.
FPM training agreement
2024 Faculty of Pain Medicine annual training agreement.
PS14(PM) Statement on responsibility for co-prescription of oral and intrathecal opioids 2023
This document outlines guidelines for the use of intrathecal opioid therapy in patients with chronic non-cancer pain, emphasizing the importance of careful patient selection, multidisciplinary assessment, and ongoing management by experienced pain medicine specialists.
PS15(PM) Persistent pelvic pain and endometriosis 2024 PILOT
This document advocates for a shift in the approach to managing persistent pelvic pain (PPP), moving away from a sole focus on endometriosis as the primary cause. It emphasizes a comprehensive, whole-person approach that addresses the complex interplay of psychological, social...
ANZCA statement on PPE
ANZCA statement on personal protection equipment (PPE) during the SARS-CoV-2
pandemic
ANZCA COVID-19 PPE Statement
Archived- ANZCA COVID-19 PPE Statement
PG52 Guideline for transport of critically ill patients 2024 (PILOT)
The aim of this document is to assist clinicians, health services and organisations develop and implement strategies and protocols for the transport of critically ill patients in order to minimise risks and maximise safety for patients and accompanying staff during transport.